What is the new drug for TED?: Teprotumumab (Tepezza) Explained
•
4 min read
In 2020, the U.S. Food and Drug Administration (FDA) approved teprotumumab (brand name Tepezza) as the first and only medication specifically for treating Thyroid Eye Disease (TED). This was a major breakthrough for a condition that had previously lacked targeted, non-surgical drug options. For patients wondering what is the new drug for TED, Tepezza represents a targeted, non-surgical advancement in treatment.
